Tipos de PSO
1. Rol del TNF-α
Múltiples enfermedades inflamatorias inmuno-mediadas comparten una vía inflamatoria común: el TNF-α.1, 2
2. ¿Qué es la psoriasis?
La psoriasis en placas es una enfermedad inflamatoria, crónica y sistématica, que afecta más allá de la piel. 4
3. Síntomas de psoriasis en placas
4. Psoriasis niños
La psoriasis afecta la autoestima, la vida social y la etapa escolar.6-9
5. Artritis Psoriásica
La artritis psoriásica afecta a 3 de cada 10 pacientes con psoriasis.5,12
6. Guías Británicas
Adalimumab, ustekinumab o secukinumab, el tratamiento recomendado de 1a línea recomendado para pacientes de Pso y APs.14
7. Terapia biológica
Para conocer más de la terapia biológica dé click en el siguiente enlace:
CONOZCA MÁS
8. Psoriasis Ungueal
Cinco cosas que debe saber sobre la psoriasis ungueal.
- Gottlieb A, Kerman N. Gordon B. Feldman SR et al. Guidelines of care for the management of psoriasis and prioritic arthritis: Section 2 Pacriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008,53.851-64
- Tracey D. Klareskog, Sasso EH et al. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacology & Therapeutics 2008, 117.244 279
- MeasePl. Gladman DD, Ritchin CT et al. Adalimumas for the Treatment of Patients with Moderately to Severely Active Psoriatic Arthritis Arthritis & Rheumatium 2005,52(10):3279-3289
- Global report on psoriasis. World Health Organization 2016
- Raychaudhuri SP, Gross). A Comparative study of Pediatric Onset Psoriasis with Adult Onset Psoriasis. Pediatric Dermatology 2000;17(3): 174-178
- Rogers M. Childhood psoriasis. Current Opinion in Pediatrics 2002 14:404-409
- Psoriasis. Report by the Secretariat. World Health Organization. 5 April 2013
- Foliadou Lazardou E, loannides D. Management of psoriasis in adolescence. Adolescent Hear Medicine and Therapeutics 2014.525-34
- Ayala F. Clinical presentation of psoriasis Reumatismo 2007.59(1):40-45
- Lin VW Tough-Skinned Kids: Identifying Psychosocial Effects of Psoriasis and helping Pediatric Patients and Families Cope Journal of Pediatric Nursing 2012:27:563-572
- National Psoriasis Fundation Comorbidities Associated with Psoriatic Disease Consultado el 30.10.15 en: http://www.prisis.org/aboutpsariasis/related conditions
- Mente A Karman Nl. Elmets CA et al. Guidelines of care for the management of psoriasis and picriatic arthritis. J Am Acad Dermatol 2011;65-137-74
- Smith CH. Jabbar-Lopez ZK. Yiu ZZ et al. British Association of Dermatologists guidelines for biologic therapy for pieriasis 2017. British Journal of Dermatology 2017,177.625-636
- Elewsky BE et al. Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial. Presented at the 5th Congress of the Psoriasis International Network (Psoriasis 2016) • Paris, France • July 7 –9, 2016.
- Radtke MA et al. Nail psoriasis – a treatment challenge. J Dtsch Dermatol Ges. 2013 Mar;11(3):203-19.
- 17. Radtke MA et al. Nail psoriasis as a severity indicator: results from the PsoReal study. Patient Relat Outcome Meas. 2011 Jul;2:1-6.
- Jiaravuthisan MM et al. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007;57:1-27.
- Samman PD, Fenton DA. Samman's The Nails in Disease. St Thomas's Hospital, St John's Institute of Dermatology. Fifth Edition. 1995.
- Reich K. Approach to managing patients with nail psoriasis. JEADV. 2009;23(Suppl. 1), 15–21.
- de Berker D. Management of Psoriatic Nail Disease. Semin Cutan Med Surg. 2009;28:39 43.
- Klaassen KMG et al. Nail psoriasis: a questionnaire-based survey. Br J Dermatol. 2013) 169, pp314-9.
- Schons KRR et al. Nail psoriasis: a review of the literatura. An Bras
- Dermatol. 2014;89(2):312-7. 24. Raposo I, Torres T. Nail psoriasis as a predictor of the Development of psoriatic arthritis. Actas Dermosifiliogr. 2015;106(6):452-7.
- Cassell SE et al. The Modified Nail Psoriasis Severity Index: Validation of an Instrument to Assess Psoriatic Nail Involvement in Patients with Psoriatic Arthritis. J Rheumatol 2007;34:123-9.
- Crowley JJ et al. Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation JAMA Dermatol. 2015;151(1):87-94.
- Langenbruch A et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. British J Dermatol. 2014;171:1123-8.
- Wilson FC et al. Incidence and Clinical Predictors of Psoriatic Arthritis in Patients With Psoriasis: A Population-Based Study. Arth Rheum. 2009;61(2):233-9.
- Nograles KE et al. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol. 2009; 5(2): 83–91.
- Doulatshahi EA et al. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. British J Dermatol. 2013;169:266-82.
- Fitzgerald O. Psoriatic arthritis. In: Firestein GS et al, eds. Kelley’s Textbook of Rheumatology. 9th ed. Philadelphia, PA: Elsevier Saunders; 2013:1232-50.
- Nestle FO et al. Psoriasis. NEJM. 2009;361:496-509.
- Lynde CW et al. Interleukin 17A: Toward a new understanding of psoriasis pathogenesis. Am Acad Dermatol http://dx.doi.org/10.1016/j.jaad.2013.12.036.
- Menter A et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol 2008;58:106-15.
MX-HUMD-240002